IMMIX BIOPHARMA, INC. (IMMX) Operating income 2020–2025
IMMIX BIOPHARMA, INC. (IMMX) annual operating income history from SEC filings — each fiscal year as reported.
-$30.0MFY2025 · since FY2020: -$453,852 → -$30.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$30.0M | -32.1% |
| FY2024 | -$22.7M | -40.5% |
| FY2023 | -$16.1M | -96.4% |
| FY2022 | -$8.2M | -507.9% |
| FY2021 | -$1.4M | -197.9% |
| FY2020 | -$453,852 | — |
Source: SEC XBRL filings · For reference only · Not investment advice